Attitudes and practices regarding the use of methadone in US state and federal prisons

Journal of Urban Health

Volumn 82, Issue 3, 2005, Pages 411-419

  Rich, Josiah D ^a,d   Boutwell, Amy E ^a   Shield, David C ^a   Key, R Garrett ^b   McKenzie, Michelle ^a   Clarke, Jennifer G ^c   Friedmann, Peter D ^c  

^a BROWN UNIVERSITY   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d MIRIAM HOSPITAL   (United States)

Author keywords

Hepatitis B; Hepatitis C; HIV; Incarceration; Methadone; Opiate dependence; Overdose; Prison; Prisoners; Recidivism

Indexed keywords

METHADONE; OPIATE;

ADMINISTRATIVE PERSONNEL; ARTICLE; COMMUNITY; DETOXIFICATION; DRUG USE; HEALTH PERSONNEL ATTITUDE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MEDICAL PERSONNEL; MEDICAL PRACTICE; OFFENDER; OPIATE ADDICTION; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PRISON; PRISONER; UNITED STATES;

DRUG UTILIZATION; FEDERAL GOVERNMENT; FEMALE; HUMANS; MALE; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; PREGNANCY; PRISONS; STATE GOVERNMENT; UNITED STATES;

EID: 23944496343     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1093/jurban/jti072     Document Type: Article

References (52)

1. Bureau of Justice Statistics. Corrections statistics: summary findings. Available at: http://www.ojp.usdoj.gov/bjs/correct.htm. Accessed May 4, 2005.
2. Federal Bureau of Investigation. Uniform crime reports: crime in the United States. Available at: http://www.fbi.gov/ucr/ucr.htm. Accessed May 4, 2005.
3. Drucker E. Drug prohibition and public health: 25 years of evidence. Public Health Rep. 1999;114:14-29.
4. Center for Disease Control and Prevention. Drug use, HIV, and the criminal justice system. IDU HIV Prevention, 2001. Available at: http://www.cdc.gov/idu/facts/criminal-justicefactsheet.pdf. Accessed May 4, 2005.
5. Califano JA. Behind Bars: Substance Abuse and America's Prison Population. Population, CASA Report. New York, New York. National Center on Addiction and Substance Abuse at Columbia University; 1998.
6. Bureau of Justice Statistics. Substance abuse and treatment of state and federal prisoners, 1999. Available at: http://www.ojp.usdoj.gov/bjs/abstract/ satsfp97.htm. Accessed May 4, 2005.
7. Hammett TD, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releases from US correctional facilities. Am J Public Health. 2002;92:1789-1794.
8. Spaulding A, Greene C, Davidson K, Schneidermann M, Rich JD. Hepatitis C in state correctional facilities. Prev Med. 1999;28:92-100.
9. Reindollar RW. Hepatitis C and the correctional population. Am J Med. 1999;107:100S-103S.
10. Centers for Disease Control and Prevention (CDC). Prevention and control of infections with hepatitis viruses in correctional settings. MMWR Morb Mortal Wkly Rep. 2003;52:1-36.
11. Rapposelli KK, Kennedy MG, Miles JR, et al. HIV/AIDS in correctional settings: a salient priority for the CDC and HRSA. AIDS Educ Prev. 2002;14:103-113.
12. Nurco DN, Hanlon TE, Kinlock TW. Recent research on the relationship between illicit drug use and crime. Behav Sci Law. 1991;9:221-242.
13. Nurco DN, Stephenson PE, Hanlon TE. Aftercare/relapse prevention and the self-help movement. Addiction. 1991;25:1179-1200.
14. Hanlon TE, Nurco DN, Kinlock TW, Duszynski KR. Trends in criminal activity and drug use over an addiction career. Am J Drug Alcohol Abuse. 1990;16:223-238.
15. Inciardi JA, McBride D, Suratt H. The heroin street addict: profiling a national population. In: Inciardi JA, Harrison LD, eds. Heroin in the Age of Crack-Cocaine. Thousand Oaks, CA: Sage; 1998:31-50.
16. Seaman SR, Brettle RP, Gore SM. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ. 1998;316:426-428.
17. Bird SM, Hutchinson SJ. Male drug-related deaths in the fortnight after release from prison: Scotland. Addiction. 2003;98:185-190.
18. Singleton N, Taylor C, Farrell M, Marsden J. Drug-Related Mortality Among Newly Released Offenders. London: Communications Development Unit, Home Office; 2003.
19. Weatherburn D, Lind B. Heroin harm minimisation: do we really have to choose between law enforcement and treatment? Crime Justice Bull. 1999;46:1-11.
20. Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area. Am J Public Health. 2001;91:1842-1846.
21. Merrill J, Alterman A, Cacciola J, Rutherford M. Prior treatment history and its impact on criminal recidivism. J Subst Abuse Treat. 1999;17:313-319.
22. Dole V, Robinson JW, Orraca J, Towns E, Searcy P, Caine E. Methadone treatment of randomly selected criminal addicts. N Engl J Med. 1969;280:1372-1375.
23. McGlothlin WH, Anglin MD, Wilson BD. Outcome of the California civil addict commitments. Drug Alcohol Depend. 1976;1:165-181.
24. McLellan AT, Arndt IO, Metzger DS, et al. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:1953-1959.
25. Magura S, Rosenblum A. Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. Mt Sinai J Med. 2001;68:62-74.
26. Sees K, Delucci K, Masson C, et al. Methadone maintenance vs. 180-day psychologically enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA. 2000;283:1303-1310.
27. Nestler EJ, Aghanajanian GK. Molecular and cellular basis of addiction. Science. 1997;278:58-63.
28. Ward J, Mattick RP, Hall W, eds. Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Australia: Harwood Academic Publishers; 1998.
29. Metzger D, Navaline H, Woody G. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;133:97-106.
30. Capelhom JRM, Ross MW. Methadone maintenance and the likelihood of risky needle-sharing. Addiction. 1995;30:685-698.
31. Newman RG, Bashkow S, Cates M. Arrest histories before and after admission to methadone. Contemp Drug Probl. 1973:417-430.
32. Center for Disease Control and Prevention. Substance abuse treatment for drug users in the criminal justice system. IDU HIV Prevention, 2002. Available at: http://www.cdc.gov/idu/facts/TreatmentFin.pdf. Accessed May 4, 2005.
33. Martin SS, Butzin CA, Saum CA, Inciardi JA. Three-year outcomes of therapeutic community treatment for drug-involved offenders in Delaware: from prison to work release to aftercare. Prison J. 1999;79:294-320.
34. Center for Disease Control and Prevention. Helping inmates return to the community. IDU HIV Prevention, 2001. Available at: http://www.cdc.gov/idu/facts/ cj-transition.pdf. Accessed May 4, 2005.
35. Grinstead O, Zack B, Faigeles B. Reducing post release risk behavior among HIV seropositive inmates: the health promotion program. AIDS Educ Prev. 2001;13:109-119.
36. Travis J, Solomon AL, Waul M. From prison to home: the dimensions and consequences of prison reentry. Urban Health Institute, 2001. Available at: http://www.urban.org/pdfs/from_prison_to_home.pdf. Accessed May 4, 2005.
37. Dolan K, Wodak A. An international review of methadone provision in prisons. Addict Res. 1996;4:85-97.
38. Sibbald B. Methadone maintenance expands inside federal prisons. CMAJ. 2002; 167:1154.
39. Dolan KA, Shearer J, MacDonald M, Mattick RP, Hall W, Wodak AD. A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend. 2003;72:59-65.
40. Fallon BM. The Key Extended Entry Program (KEEP): from the community side of the bridge. Mt Sinai J Med. 2001;68:21-27.
41. Tomasino V, Swanson AJ, Nolan J, Shuman HI. The Key Extended Entry Program (KEEP): a methadone treatment program for opiate-dependent inmates. Mt Sinai J Med. 2001;68:14-20.
42. Gerra G, Ferri M, Polidori E, Santoro G, Zaimovic A, Sternieri E. Long-term methadone maintenance effectiveness: psychosocial and pharmacological variables. J Subst Abuse Treat. 2003;25:1-8.
43. Office of National Drug Control Policy. Consultation Document on Methadone/LAAM. Washington, DC:ONDCP; 1998.
44. Warren E, Viney R. CHERE: an economic evaluation of the prison methadone program in New South Wales, 2004: Available at: http://www.chere.uts.edu.au/pdf/ rep22.pdf. Accessed May 4, 2005.
45. Clarke JG, Stein MD, Hanna L, Sobota M, Rich JD. Active and former IDU report of HIV risk behaviors during periods of incarceration. Subst Abuse. 2001;22:209-216.
46. Calzavara LM, Burchell AN, Schlossberg J, et al. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction. 2003;98:1257-1265.
47. Koulierakis G, Gnardellis C, Agrafiotis D, Power KG. HIV risk behaviour correlates among injecting drug users in Greek prisons. Addiction. 2000;95:1207-1216.
48. Champion JK, Taylor A, Hutchinson S, et al. Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study. Am J Epidemiol. 2004;159:514-519.
49. Macalino GE, Vlahov D, Sanford S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;4:1218-1223.
50. Magura S, Rosenblum A, Joseph H. Evaluation of in-jail methadone maintenance: preliminary results. NIDA Research Monograph. 1992;118:192-210.
51. Rich JD, McKenzie M, Carleton JC, Rizzi MA, Wolf FA, Crosland C. Linkage to methadone upon release from incarceration: a model. Paper presented at: APHA 131st Annual Meeting; November 19, 2003; San Francisco.
52. United States Code of Federal Regulations Certification of Opioid Treatment Programs, 42 CFR §8, 2005. Available at: http://dpt.samhsa.gov/ otp.htm. Accessed May 4, 2005.